Join
Search

Posts Tagged ‘label claims’

Weaker Antibiotic Regulation: Another Problem with FDA’s Voluntary Cooperation Program

Last post, I described some of the features of the voluntary process that might convince veterinary drug companies to give up lucrative approvals to sell antibiotics for production purposes, like growth promotion and feed efficiency. Read More

Bookmark and Share

Negotiating with Drug Companies: The Horse-Trading Behind the FDA’s Voluntary Program

After decades of dragging its feet on the issue, the FDA has finally acknowledged that the ongoing massive use of antibiotics in food animal production poses a public health risk that demands a response. Read More

Bookmark and Share